Why the study?
Management of tricuspid regurgitation in congenitally corrected transposition of the great arteries is challenging, and data on percutaneous repair in these patients are limited.
Population
CCTGA patients with moderate-severe TR at high surgical risk
Answers are grounded in this paper and cite their sources.
Reports clinical experience with transcatheter tricuspid valve repair in high-risk congenitally corrected transposition of the great arteries, highlighting feasibility.
Introduction In congenitally corrected transposition of the great arteries (CCTGA) the right ventricle (RV) is the systemic ventricle. RV dysfunction and significant regurgitation of the systemic tricuspid valve are common and associated with worse outcomes. Management of tricuspid regurgitation (TR) in CCTGA is challenging. In acquired cardiovascular disease, percutaneous repair of mitral valve regurgitation (MR) is established. Data on CCTGA with TR are limited1. We report our experience with this technique in these patients. Methods CCTGA patients with moderate-severe TR were eligible if surgery was deemed high-risk. Interventional therapy was offered, and patients provided written informed consent. ...
No takes yet. Share an insight, caveat, or question.
Ott et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: